maprotiline has been researched along with lorazepam in 9 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (22.22) | 18.7374 |
1990's | 1 (11.11) | 18.2507 |
2000's | 4 (44.44) | 29.6817 |
2010's | 2 (22.22) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Topliss, JG; Yoshida, F | 1 |
Gao, F; Lombardo, F; Obach, RS; Shalaeva, MY | 1 |
Lombardo, F; Obach, RS; Waters, NJ | 1 |
Choi, SS; Contrera, JF; Hastings, KL; Kruhlak, NL; Sancilio, LF; Weaver, JL; Willard, JM | 1 |
García-Mera, X; González-Díaz, H; Prado-Prado, FJ | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Barbotin-Larrieu, P; Guerin, JM; Lustman, C | 1 |
Calvert, JE; Gelbtuch, MH; Harris, JP; Phillipson, OT | 1 |
Hertrich, O | 1 |
1 review(s) available for maprotiline and lorazepam
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
8 other study(ies) available for maprotiline and lorazepam
Article | Year |
---|---|
QSAR model for drug human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
Prediction of human volume of distribution values for neutral and basic drugs. 2. Extended data set and leave-class-out statistics.
Topics: Algorithms; Blood Proteins; Half-Life; Humans; Hydrogen-Ion Concentration; Models, Biological; Pharmaceutical Preparations; Pharmacokinetics; Protein Binding; Statistics as Topic; Tissue Distribution | 2004 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models.
Topics: | 2008 |
Multi-target spectral moment QSAR versus ANN for antiparasitic drugs against different parasite species.
Topics: Antiparasitic Agents; Molecular Structure; Neural Networks, Computer; Parasitic Diseases; Quantitative Structure-Activity Relationship; Species Specificity; Thermodynamics | 2010 |
Acute voluntary life-threatening carbonate lithium poisoning.
Topics: Adult; Female; Humans; Lithium; Lithium Carbonate; Lorazepam; Maprotiline; Suicide, Attempted | 1990 |
Modification of visual orientation illusions by drugs which influence dopamine and GABA neurones: differential effects on simultaneous and successive illusions.
Topics: Adolescent; Adult; Dopamine; Female; gamma-Aminobutyric Acid; Haloperidol; Humans; Illusions; Lorazepam; Male; Maprotiline; Neurons; Nomifensine; Optical Illusions; Orientation | 1986 |
[Ataractic treatment in psychiatry and general medicine. Review of preparations. 9].
Topics: Adjustment Disorders; Anthracenes; Anti-Anxiety Agents; Benzodiazepines; Humans; Lorazepam; Maprotiline; Medazepam; Neurotic Disorders; Psychophysiologic Disorders; Psychotic Disorders; Sleep Wake Disorders; Tranquilizing Agents | 1983 |